Extracorporeal photopheresis in the treatment of persistent rejection in a pediatric lung transplant recipient

Progress in Transplantation

Volumn 13, Issue 1, 2003, Pages 61-64

  Wise, Barbara V ^a,b   King, Karen E ^b   Rook, Alain H ^c   Mogayzel, Peter J ^d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d JOHNS HOPKINS CHILDREN S CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACLIZUMAB; METHOXSALEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PSORALEN; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; CYSTIC FIBROSIS; FEMALE; FEVER; GRAFT REJECTION; HLA MATCHING; HUMAN; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; LUNG INSUFFICIENCY; LUNG TRANSPLANTATION; MALABSORPTION; PANCREAS INSUFFICIENCY; PUVA; ULTRAVIOLET A RADIATION;

EID: 0037334687     PISSN: 15269248     EISSN: None     Source Type: Journal    
DOI: 10.7182/prtr.13.1.217290w32455833w     Document Type: Article

References (20)

1. Davis PB, Drumm, Konstan MW. Cystic fibrosis. Am J Respir Crit Care Med. 1996;154:1229-1256.
2. International Society for Heart and Lung Transplantation. Available at: http://www.ISHLT.org. Accessed September 1, 2002.
3. UNOS update 2002. Available at: http://www.UNOS.com. Accessed September 1, 2002.
4. Kelly K, Hertz MI. Obliterative bronchiolitis. Clin Chest Med. 1997;18:319.
5. Bush WW. Overview of transplantation immunology and the pharmacotherapy of adult solid organ transplant recipients: focus on immunosuppression. AACN Clin Issues. 1999;10:253-269.
6. Arcasoy SM, Kotloff RM. Lung Transplantation. N Engl J Med. 1999;340:1081-1091.
7. Salerno CT, Park SJ, Kreykes NS, et al. Adjuvant treatment of refractory lung transplant rejection with extracorporeal photopheresis. J Thorac Cardiovasc Surg. 1999;117:1063-1069.
8. Kirklin JK, Bourge RC, McGiffin DC. Recurrent or persistent cardiac allograft rejection: therapeutic options and recommendations. Transplant Proc. 1997;29(suppl 8A):40S-44S.
9. Rook AH, Suchin R, Kao DM, et al. Photopheresis: clinical applications and mechanisms of action. J Investig Dermatol. 1999;4(1 suppl):85-90.
10. Dall'Amico R, Montini G, Murer L, et al. Benefits of photopheresis in the treatment of heart transplant patients with multiple/refractory rejection. Transplant Proc. 1997;29:609-610.
11. Wolfe JT, Lessin SR, Singh AH, Rook AH. Review of immunmodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection. Artif Organs. 1994;18:888-897.
12. Schürfeld K, Giunti M, Rubegni P, et al. Photopheresis after cardiac transplantation induces apoptosis. Transplant Proc. 1999;3:125-127.
13. Schoch OD, Boehler A, Speich R, Nestle FO. Extracorporeal photochemotherapy for Epstein-barr virus-associated lymphoma after lung transplantation. Transplantation. 1999;68:1056-1058.
14. Yoo ER, Rook AH, Elenitsas R, Gasparo FP, Vowels BR. Apoptosis induction by ultraviolet light A and photochemotherapy in cutaneous T cell lymphoma: relevance to mechanism of action. J Investig Dermatol. 1996;107:235-242.
15. Russell-Jones R. Shedding light on photopheresis. Lancet. 2001;357:820-821.
16. O'Hagan AR, Stillwell PC, Arrogolia A, Koo A. Photopheresis in the treatment of refractory bronchiolitis obliterans complicating lung transplantation. Chest. 1999;115:1459-1462.
17. Dall'Amico R, Murer L, Montini G, et al. Successful treatment of recurrent rejection in renal transplant patients with photopheresis. J Am Soc Nephrol. 1998;9:121-127.
18. Barr ML, Meiser BM, Eisen HJ, et al. Photopheresis for the prevention of rejection in cardiac transplantation. N Engl J Med. 1998;339:1744-1755.
19. Villanueva J, Bhorade SM, Robinson JA, Husain AN, Garrity ER. Extracorporeal photopheresis for the treatment of lung allograft rejection. Ann Transplant. 2000;5(3):44-47.
20. Mogayzel PJ Jr, Wise BV, Yang SC, Zachary AA, Colombani PM. An unusual case of fatal pulmonary allograft rejection. Pediatr Transplant. 2001:5:138-141.